EARN25

Biotech Blasts to Record Highs After Upbeat Trial Data

Options volume is surging as well

Deputy Editor
Jun 28, 2021 at 10:43 AM
facebook X logo linkedin


The shares of biotechnology name Intellia Therapeutics Inc (NASDAQ:NTLA) are soaring this morning, up 48% to trade at $131.92 at last check -- earlier hitting a record high of $144.39 -- after positive data from the company's early-stage trial of its genome-editing candidate, NTLA-2001. The treatment, which is being created in collaboration with Regeneron (REGN), is for transthyretin amyloidosis. In response, no fewer than four analysts raised their price targets, with the highest from H.C Wainwright to $171 from $111. 

Today's abrupt jump has NTLA breaking out past pressure at the $90 level, as well as enjoying a bull gap to record highs. With help from the 30-week moving average, a trendline of close support for over a year, the equity is up around 532% year-over-year. However, the equity could be due for a correction, as per the stock's 14-Day Relative Strength Index (RSI) of 65, which is nearing "overbought" territory. 

Options volume is taking off alongside NTLA's price action. So far, 4,430 calls and 5,280 puts have crossed the tape, which is 11 times what's typically seen at this point. The most active option is the July 130 call, where new positions are being opened. 

Meanwhile, the 6.54 million shares sold short make up a solid 10.9% of Intellia stock's available float. In other words, it would take over a week to buy back these bearish bets, at NTLA's average pace of trading. 

 

You Don’t Need 25 Alerts -- You Need ONE You Can Trust!

That’s the idea behind Trade of the Week, Schaeffer’s newest trade alert.

Every Monday morning before the opening bell, you’ll receive a single, expertly researched trade recommendation -- built from the same proprietary research we’ve been using for over four decades.

It’s not just a signal.

It’s a plan designed for traders who are tired of jumping from alert to alert without ever finding their edge.

No juggling alerts. No switching directions mid-week. Just one clear, expertly researched trade idea -- delivered before the market even opens.

👉 JOIN RIGHT NOW FOR JUST $1 TO GET THE NEXT TRADE!